R. Dustan Sarazan - Concepedia

Author

R. Dustan Sarazan

Eli Lilly (United States)

Also Known As

R D Sarazan, R Sarazan, R. D. SARAZAN, R. D. Sarazan, R. Dustan Sarazan, R.D. Sarazan, R.Dustan Sarazan

Publications

979

Citations

H-Index

Concepts

All Affiliations

Eli Lilly (United States)Covance (United States)Data Sciences International (United States)Health and Environmental Sciences Institute Boehringer Ingelheim (Germany)

About

R. Dustan Sarazan is an author at Eli Lilly (United States) specializing in medicine, anesthesiology, and cardiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	420
2	Public Health	3	3	115
3	Engineering	1	1	17
4	Health Sciences	1	1	58
5	Social Sciences	1	1	89

R. Dustan Sarazan

Publications

853

Citations

H-Index

Page 1

	Year	Citations
Three-Dimensional Quantitative Structure-Activity Relationship for Inhibition of Human Ether-a-Go-Go-Related Gene Potassium Channel Sean Ekins, William Crumb, R. Dustan Sarazan, Journal of Pharmacology and Experimental Therapeutics	2002	257
Effects of Antipsychotic Drugs on Ito, INa, Isus, IK1, and hERG: QT Prolongation, Structure Activity Relationship, and Network Analysis William Crumb, Sean Ekins, R. Dustan Sarazan, Pharmaceutical Research Structure Activity RelationshipPsychoactive DrugPsychiatryMedicineAntipsychotic Drugs	2006	89
Cardiovascular Function in Nonclinical Drug Safety Assessment R. Dustan Sarazan, Scott W. Mittelstadt, Brian D. Guth, International Journal of Toxicology Drug SafetyCardiovascular ToxicityHypertensionHeart FailureCardiovascular Translational Research	2011	74
Sensitivity of two noninvasive blood pressure measurement techniques compared to telemetry in cynomolgus monkeys and beagle dogs Andrea Z. Mitchell, Carrie McMahon, Tom W. Beck, Journal of Pharmacological and Toxicological Methods Veterinary PhysiologyHypertensionPressure MeasurementCynomolgus MonkeysPhysiology	2010	58
The evaluation of drug-induced changes in cardiac inotropy in dogs: Results from a HESI-sponsored consortium Brian D. Guth, Alan Y. Chiang, Jennifer Doyle, Journal of Pharmacological and Toxicological Methods	2015	54
Cardiovascular effects of detomidine, a new α<sub>2</sub>‐adrenoceptor agonist, in the conscious pony R. Dustan Sarazan, W. A. STARKE, G. F. Krause, Journal of Veterinary Pharmacology and Therapeutics	1989	51
Cardiovascular effects of the macrolide antibiotic tilmicosin, administered alone and in combination with propranolol or dobutamine, in conscious unrestrained dogs Bradley W. Main, Jeffrey R. Means, Lynn E. Rinkema, Journal of Veterinary Pharmacology and Therapeutics	1996	44
Evaluation of blood pressure measurement using a miniature blood pressure transmitter with jacketed external telemetry in cynomolgus monkeys Carrie McMahon, Andrea Z. Mitchell, Jessica L. Klein, Journal of Pharmacological and Toxicological Methods Jacketed External TelemetryHypertensionPressure MeasurementBlood Pressure MeasurementCynomolgus Monkeys	2010	44
Left ventricular pressure, contractility and dP/dtmax in nonclinical drug safety assessment studies R. Dustan Sarazan, John P. Kroehle, Bradley W. Main Journal of Pharmacological and Toxicological Methods HypertensionHeart FailureCardiac AnaesthesiaCardiovascular DiseaseCardiac Mechanic	2012	35
Absence of clinically important HERG channel blockade by three compounds that inhibit phosphodiesterase 5—sildenafil, tadalafil, and vardenafil R. Dustan Sarazan, William Crumb, Charles M. Beasley, European Journal of Pharmacology Molecular PharmacologyMedicinePhosphodiesterase 5—SildenafilPhysiologyPharmacotherapy	2004	33

Page 1